STYRENE MALEIC ANHYDRIDE BASED FORMULATION FOR MALE CONTRACEPTION AND PROSTATE CANCER,
- 专利权人:
- 发明人:
- 申请号：
- IN618/DEL/2008
- 公开号：
- IN287045B
- 申请日:
- 2008.03.11
- 申请国别(地区):
- IN
- 年份:
- 2017
- 代理人:
- 摘要：
The invention provides a styrene maleic anhydride based synergistic formulation comprising styrene maleic anhydride [SMA] having lower molecular weight and styrene maleic anhydride [SMA] having higher molecular weight dissolved in DMSO, and being capable of preventing the prostate cancer as well as causing male contraception even when administered in smaller doses for one or two administrations in the life time and predominantly causing no or minimal side effects, and still being reasonably affordable by common man, and the formulation being capable of traveling along the vas deferens after causing male contraception in the vas deferens to the prostate gland and getting absorbed into the epithelial zone of the prostate gland.
[WO2009113108A2]
- 来源网站：
- 中国工程科技知识中心
